From virus to inflammation, how influenza promotes lung damage

Area of Science:

• Immunology
• Pulmonology
• Infectious Diseases

Background:

• Influenza causes acute lung injury and secondary bacterial pneumonia, leading to significant hospitalizations and mortality.
• Current seasonal vaccines have not reduced influenza-related hospitalization and death rates over the past five years.
• Effective influenza therapeutics require understanding immune mechanisms driving lung damage and secondary infections.

Purpose of the Study:

• To review pathogenic immune mechanisms in influenza-induced acute lung injury.
• To explore the potential of targeting lung inflammation and barrier crosstalk for novel therapeutics.
• To identify strategies for mitigating inflammation, enhancing antiviral immunity, and preventing secondary bacterial diseases.

Main Methods:

• This is a review article, synthesizing existing research on influenza pathogenesis and immune responses.
• Literature search focused on immune mechanisms, acute lung injury, secondary bacterial pneumonia, and therapeutic targets.
• Analysis of inflammatory pathways and lung barrier integrity in the context of influenza infection.

Main Results:

• Influenza pathogenesis involves complex immune responses leading to acute lung injury.
• Secondary bacterial pneumonia is a major complication, increasing disease burden.
• Lung inflammation and barrier dysfunction are critical factors in influenza severity.

Conclusions:

• A comprehensive understanding of damage-associated immune mechanisms is crucial for developing effective influenza therapeutics.
• Targeting lung inflammation and barrier crosstalk offers promising avenues for therapeutic intervention.
• Interventions should aim to mitigate inflammation, improve antiviral immunity, and prevent secondary bacterial infections.